CV Sciences Inc (CVSI)

[Deetew]

Key talking points:

WARNING: Some will do everything in their power to get this below $4 to block a NASDAQ uplisting.

It is the goal to keep this in the less regulated OTC since some play the volatility, and it's a big source of income. It's easy to manipulate a stock in the OTC, so some have no desire to see it reach NASDAQ status. Some will do everything to scare new investors and shake holding investors. It would be stupidity to sell your shares.

1) Do not set stop losses; stop losses create a chain reaction effect when highly coordinated sellers all sell their shares at the same time, which triggers the stop losses. It's a known scam!

2) Set 60 day limit sell orders for $150 per share to block some from being able to grab your shares. These strategies will be effective at reducing the impact of coordinated sell-offs. Volatility will be much less after a NASDAQ uplisting when the big dogs join into the fun. Follow this strategy to win. Do not sell. Hold. Buy more. Good game.

Click here for more information

Does this look final to you?

----------------------------------------------------------------------------

The 3 day trading rule and an awesome investor news article

CVSI is a BUY folks. The 3 day trading rule suggests that an upswing is coming. The lawsuits are still meritless. This company will outperform TLRY. Read this article from the sector's top investor site to confirm this to yourselves. These guys don't put out many articles on cannabis (less than 1 article a month).

See here: This Company Has Better Numbers than Tilray at 1/25th the Price

----------------------------------------------------------------------------

CVSI is being artificially held down (Regarding the patent in question)

I see it as though the stock is being artificially held down by the meritless lawsuits whereas Citron Research failed to advise investors that the patent is still pending thus not final. The finality of a final rejection is automatically withdrawn after a "final" rejection is appealed. Material standards for patent disclosure suggest that since CVSI's patent was not a core part of the business, CVSI did not have to disclose the non-final "final" rejection --especially considering the fact that CVSI has made not a single dime of revenue off of the patent. The stock at the time was moving up as a result of earnings --not the patent in question. The sell-off resulted due to the fact that Mona had SEC issues in the past, so the credibility of CVSI was at question, but the revenue-less patent itself had nothing to do with the sell-off. New investors should consider this period of time as a great opportunity to buy while the stock is being artificially held down.

Keep in mind that the SEC issue from the past regarding Mona was already settled, and Mona was forced to step down as CEO. I hold Citron Research at fault for the sell-off since they failed to disclose to investors that the patent in question is still pending right now as of 9/29/18.

I don't expect CVSI to ignore the lawsuits. I expect them to take them very seriously, and I'm sure they will. CVSI has responded to the lawsuits on more than one occasion by PR, but I wouldn't expect a conservative CEO to spend outrageous amounts of money through PR to continuously remind investors that the finality of a final rejection is anything but final. Such actions would be redundant and wasteful of shareholder dollars --especially considering the importance of maximizing shareholder wealth in the long-term. CVSI's responses are available by Google search, so it's up to the investor to do his/her own DD regarding the lawsuits. In due time, all will be revealed. I think the continuous re-posts of the lawsuits on CVSI's ticker should be made unlawful, because it is quite ridiculous.

The lawsuits will only show in the newsfeed for so long. Smart investors that do their DD will realize this. I think all prices at these levels are ridiculously low, so anyone that gets in now (unless the investor is a day-trader) and holds for a longer-term position should be rewarded upon a good Earnings statement, Farm Bill passage, NASDAQ uplisting, a possible deal with a large company, and many other catalysts in the near future (within months).

CRITICAL INFO ON PATENTS

---------------------------------------------------------------------------

CBD by itself is unpatentable. Only concoctions are patentable.

Coca Cola's (and the like) lobbying power should be sufficient to get things moving in the right direction. Keep in mind that Epidiolex is not 100% CBD. It is a concoction that contains about 95% CBD. This concoction is what allowed them to get a patent in the first place; patents can not be given for plant extracts and isolates alone. It's important to realize this. CVSI utilizes extracts from the legal parts of the legally imported hemp plant that contain less than .3% THC. These particular extracts are not patentable at all since CVSI's concoctions do not change the physiological effect resulting from the CBD within them.

To Patent or Not To Patent: Are Natural Products Off the Table?

---------------------------------------------------------------------------

The legality of CVSI's product: They aren't breaking any laws --federal or state

Why CVSI isn't breaking the law

---------------------------------------------------------------------------

Cannabis' schedule 1 status is untenable:

See why here

----------------------------------------------------------------------------

FDA/DEA scandals and more:

U.S. Government and Top Mexican Drug Cartel Exposed as Partners

Business Insider: CONFIRMED: The DEA Struck A Deal With Mexico's Most Notorious Drug Cartel

See here to realize just how corrupt the FDA and DEA are

Queen Elizabeth II & George Bush, the world's biggest drug dealers

---------------------------------------------------------------------------

These talking points seem to be very relevant right now. They should provide you with the ammunition that you need to shut down pathetic arguments. CVSI is not breaking any laws that should hurt a NASDAQ uplisting. More to come. Over and out.